Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Conference News ESC 2019

ESC Updates Guidance on Management of Acute Pulmonary Embolism

Todd Neale

September 06, 2019

News Daily News

Varicose Veins Linked to Increased Risk of DVT

L.A. McKeown

February 28, 2018

News Daily News

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Yael L. Maxwell

April 11, 2017

News Daily News

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

L.A. McKeown

March 06, 2012

Advertisement

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

November 2024 Dispatch for the CV Team

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

October 2023 News Roundup

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

ESC Updates Guidance on Management of Acute Pulmonary Embolism

Varicose Veins Linked to Increased Risk of DVT

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content